Safety and immunogenicity of the LC16m8 vaccine against mpox during outbreak deployment in Colombia: a hybrid, multicentre, open-label, randomised controlled trial and observational cohort study
BACKGROUND: LC16m8 is a live-attenuated, replication-competent vaccinia vaccine, but clinical evidence on its efficacy against mpox remains limited. We assessed its efficacy and safety in adults at increased risk of mpox in Colombia. METHODS: We conducted a hybrid study comprising a multicentre, open-label, randomised delayed-vaccination trial and an observational cohort at three centres in Bogotá. Adults aged 18-50 years were randomised 1:1 using stratified permuted blocks to receive one percutaneous dose of LC16m8 at enrolment (Day 0) or on Day 42. The primary outcome was PCR-confirmed mpox during the arm-specific efficacy-assessment windows, analysed in the per-protocol efficacy population; no efficacy outcomes were imputed. Safety outcomes were assessed through Day 180. CLINICALTRIALS: govNCT06223919; retrospectively registered; trial closed to recruitment. FINDINGS: Between December 16, 2023, and January 6, 2024, 208 participants were enrolled and 204 randomised (104 immediate; 100 delayed); 203 were male and one female. The trial randomised 204 of 8686 planned participants. No PCR-confirmed mpox cases occurred in the primary per-protocol efficacy analysis (0/97 immediate vs 0/69 delayed); therefore, the prespecified hazard ratio, 95% CI, p value, and vaccine efficacy were not estimable. Through Day 180, at least one adverse event was reported by 96/98 (98·0%) participants in the immediate-vaccination group and 68/69 (98·6%) in the delayed-vaccination group. One serious adverse event occurred in each group; both were unrelated to vaccination and resolved. No deaths or adverse-event-related study discontinuations occurred. INTERPRETATION: Substantial under-recruitment and the absence of primary outcome events precluded estimation of LC16m8 efficacy. The randomised safety findings were limited by the small sample size. FUNDING: Japan Agency for Medical Research and Development (AMED; JP22fk0108503h0001); Ministry of Health and Social Protection of Colombia; Universidad Nacional de Colombia; National Institute of Health of Colombia.
Authors
- Akira Ainai (ORCID: https://orcid.org/0000-0003-3054-8846)
- Sandra Valderrama (ORCID: https://orcid.org/0000-0003-1833-1599)
- Sandra Susana Novoa-Herrán (ORCID: https://orcid.org/0000-0003-2157-1008)
- Hernando Gaitán‐Duarte (ORCID: https://orcid.org/0000-0003-2939-3648)
- Naoki Tomotsugu (ORCID: https://orcid.org/0000-0002-5874-7962)
- Sohtaro Mine (ORCID: https://orcid.org/0000-0002-4912-4077)
- Laura Cristina Nócua-Báez (ORCID: https://orcid.org/0000-0003-2869-2339)
- Diego Alejandro Álvarez-Díaz (ORCID: https://orcid.org/0000-0002-6534-0079)
- Yasukata Ohashi (ORCID: https://orcid.org/0009-0007-5613-6053)
- Alejandra M. Muñoz-Suarez (ORCID: https://orcid.org/0000-0001-5112-5960)
- Milagros Virhuez-Mendoza (ORCID: https://orcid.org/0000-0002-8357-2498)
- Tadaki Suzuki (ORCID: https://orcid.org/0000-0002-3820-9542)
- Mugen Ujiie (ORCID: https://orcid.org/0000-0001-8150-075X)
- Mieko Hamana
- Norio Ohmagari (ORCID: https://orcid.org/0000-0002-4622-8970)
- Otto Sussman
- Carlos Álvarez (ORCID: https://orcid.org/0000-0001-5419-4494)
- Shiori Ueno
- Carlos Gómez (ORCID: https://orcid.org/0000-0002-8987-9351)
- Jorge Alberto Cortés (ORCID: https://orcid.org/0000-0002-0882-9652)
- Johana Hernández
- Gloria Mercedes Puerto
- Maria Jose Amaya Mahecha (ORCID: https://orcid.org/0000-0001-6110-3116)
- María Del Mar Bautista-Gonzalez
- Ken Maeda
- Jaime Castellanos
- Valentina Guevara-Prieto
- Claudia Marcela Castro-Osorio
- Luz Mery González
Institutions
- Pontificia Universidad Javeriana (CO)
- Universidad Nacional de Colombia (CO)
- Instituto Nacional de Salud (CO)
- Hospital Universitario San Ignacio (CO)
- Fundación Universitaria Sanitas (CO)
- Japan Institute for Health Security (JP)
Publication Details
- Journal
- EBioMedicine
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1016/j.ebiom.2026.106549
- Primary Topic
- Poxvirus research and outbreaks
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Instituto Nacional de Salud
- Japan Agency for Medical Research and Development
- Universidad Nacional de Colombia
- Ministerio de Salud y Protección Social